The major house-dust-mite allergen, Der p I, stimulates the phospholipase D (PLD) in peripheral blood mononuclear cells (PBMC) from allergic patients with maximal responses after 30 min exposure. At 30 min, Der p I stimulated PLD activity by 1.4-fold in mild, 1.6-fold in moderate and 2-fold in severe allergic patients over control values (p < 0.05). When the cells were pretreated for 24 h with phorbol myristate acetate to down-regulate protein kinase C (PKC), PLD stimulation by Der p I was largely abolished. These results indicate that in PBMC from allergic patients, Der p I can stimulate PLD activity, and that PKC activation is involved in this stimulation.
Introduction
House dust mites (HDM) are the most common source of aeroallergens, which can cause clinical symptoms ranging from extrinsic asthma to atopic dermatitis (Hoyne et al., 1996) . One of the major mite allergens, designated Der p I, has been purified from D. pteronyssinus and shown to react with anti-mite IgE antibodies in up to 80% of allergic sera (Lind and Lowenstein, 1983; Krillis et al., 1984) . High levels of anti-Der p I IgE, IgA and IgG are present in 90% of patients who have positive skin tests to Der p I extracts, whereas nonsensitized subjects have only low titers of anti Der p I IgG (Platts and Chapman, 1987; Roche et al., 1997) .
Der p I is the first HDM allergen cloned by recombinant DNA technology (Chua et al., 1988; Dilworth et al., 1991) . The cDNA analysis showed that they are cysteine proteases in the same family as papain and actinidin and have 222 residues with a calculated MW of 25 kD (Thomas and Smith, 1998) . The cysteine protease activity of Der p I increases airway mucosal permeability, and may thereby contribute to the pathogenesis of airway inflammation and hyperresponsiveness by a nonimmunological mechanism (Roche et al., 1997) .
It has been reported that Der p I induces proliferative T cell responses in the majority of patients with asthma and atopic dermatitis, who are sensitized to Der p I (Rawle et al., 1984; OBrien et al., 1992) . Recently, several investigators have suggested that the mite-specific proliferating T cells are mainly type 2 T-helper (Th2) cells secreting interleukin-4 and -5 (Looney et al., 1994) .
Despite these increasing data, very little attention has been given to the potential intracellular signaling mechanisms of the pathogenesis induced by HDM allergens. It is well known that ligation of the antigen receptors on T cells (TCR) results in the activation of key signal transducing systems such as the phosphatidylinositol 4,5-bisphosphate (PIP 2 )-specific phospholipase C-γ (PLC-γ) and increase of intracellular free Ca 2+ concentration (Howe and Weiss, 1995) . However, T cell activation, via the TCR, has been shown to occur in the absence of activation of PLC (ORourke and Mescher, 1988) . Moreover, the growing body of evidence has indicated that PLC-mediate hydrolysis of PIP 2 is not sufficient to stimulate cell proliferation (Exton, 1994) .
In recent years, phosphatidylcholine (PC)-hydrolysis by phospholipase D (PLD) has been suggested to play an important role in proliferative responses of a wide range of mitogens and growth factors (Exton, 1997) . PLD catalyzes the hydrolysis of phospholipids, mainly PC, resulting in the formation of phosphatidic acid (PA), which acts by itself as a cellular messenger (Exton, 1990) or can be transformed by PA phosphohydrolase into diacylglycerol (DAG), which is essential for the activation of protein kinase C (PKC) (Nishizuka, 1995) . More recently, PLD has been shown to be coupled to TCR in the leukemic T cell line, Jurkat, resulting in the induction of proliferation of T cells (Reid et al., 1997) .
In this study, we report that the HDM allergen, Der p I induces PLD activation in PBMC isolated from allergic patients. In addition, we also demonstrate that the activation of PLD is partially regulated by PKC. These results suggest a potentially important role of PLD in Der p I-induced allergenic pathogenesis.
Materials and Methods

Subjects
Seven patients who referred with symptoms of allergic diseases and had positive skin prick tests to house dust mite extracts (Dermatophagoides farinae and Dermatophagoides pterynyssinus) were studied. The mean age of the patients was 27 years old (range: 22 to 34 years). Among the healthy people who do not have any clinical and family history of allergy, three healthy volunteers with serum IgE values less than 150 IU/mL were included.
Skin prick tests and Serum IgE levels
Skin prick tests were performed with allergen extracts of house dust mite (ALK, Denmark & Greer Lab, USA). Histamine was used as a positive control (10 mg/ml), and a diluent of an unbuffered saline containing 0.03% human serum albumin (ALK, Copenhagen, Denmark), was used as a negative control. Reactions to each skin test solution were measured 15 min after the pricks. The contours of each wheal reaction were outlined with a fine filter tip pen. The contours were then transferred to the record sheet by means of translucent tapes. The size of each wheal is documented as the mean of the longest diameter (a) and the diameter perpendicular to it at its mid-point (b): (a + b)/2. Wheals with more than half of the histamine reaction after subtracting the response to the diluent control were considered as expressions of clear-cut positivity. Total serum IgE was measured by the paper radioimmunosorbent test (KabiPharmacia, Uppsala, Sweden). The lower detection limit of IgE was < 1.5 IU/ml.
PBMC culture
Heparinized blood (100~150 ml) was collected from donors sensitized or nonsensitized to Der p I and peripheral blood mononuclear cells (PBMC) were purified from heparinized blood by density gradient centrifugation as previously described (Nasert et al., 1996) . The cells were washed three times in Hank's balanced salt solution and cultured at 37 o C in RPMI-1640 medium (Gibco BRL, USA) supplemented with 10% (v/v) FBS, 100 units/ml penicillin and 100 µg/ml streptomycin. Cells grown at 37 o C in a humidified CO 2 controlled (5%) incubator were then washed with RPMI-1640 medium containing 0.1% (w/v) bovine serum albumin, 100 units/ ml penicillin and 100 µg/ml streptomycin (serum-free medium) and incubated in a serum-free medium at 37 o C for 1 day before the treatment with Der p I (No. 70720, Allergopharma Joachim Ganzer, Hamburg, Germany).
Determination of PLD activity
PLD activity was determined by the formation of PEt as described elsewhere . Briefly, PBMC cultured on 6-well plates were metabolically labeled with 1 µCi/ml of [ 3 H]palmitate in serum free medium for 18 h. The cells were then pretreated with 1% ethanol for 15 min before the treatment with Der p I. In some experiments the cells were treated with phorbol myristate acetate (PMA) (100 nM) for 24 h to down-regulate PKC before labeling with [ 3 H]palmitate. After treatment of Der p I for the designated time, the cells were quickly washed with ice-cold PBS and suspended in ice-cold methanol. Lipids were extracted according to the method of Bligh and Dyer (Bligh and Dyer, 1959) , and PEt was separated by a thin layer chromatography using a solvent system of ethyl acetate/iso-octane/acetic acid/water (110:50:20:100, v/v) (Park et al., 1999) . The regions corresponding to the authentic PEt bands were identified with 0.002% (w/v) primulin in 80% (v/v) acetone, scraped and counted using a liquid scintillation counter.
Results
The patients were divided into three categories (severe, moderate and mild) on the basis of clinical severity. The total IgE level in serum of severe allergic patients (3,227 ± 179.5 IU/ml) was significantly higher than in those of moderate (2,378 ± 238.3 IU/ml) and mild (1,354 ± 155.7 IU/ml) allergic patients and normal control (43 ± 5.5 IU/ ml) as shown Table 1 . The effects of Der p I (10 mg/ml) on PLD activity in PBMC from normal individuals (as a control) and allergic patients after various times of exposure are illustrated in Figure 1 . A significant effect on PLD activity was seen in PBMC from allergic patients after 20 min of treatment with Der p I. The PLD activity was increased above normal values after Der p I treatment at each time point examined, with maximal responses after 30 min exposure. At 30 min, Der p I stimulated PLD activity by 1.4-fold in mild, 1.6-fold in moderate and 2-fold in severe allergic patients over control values (p < 0.05).
To determine whether Der p I-induced PLD stimulation occurred as a consequence of PKC activation, PBMC were exposed to PMA (100 nM) for 24 h before the treatment of Der p I. The results are illustrated in Figure 2 . PKC down-regulation by the long-term treatment of PMA had no intrinsic effect on basal PLD activity. PLD activity in allergic PBMC that were previously down-regulated was significantly diminished compared to that in Der p I-treated non-PKC down-regulated cells (p < 0.05). Although PLD activity in PKC downregulated cells of allergic patients was still significantly higher than that in the equivalent normal PBMC (p < 0.05), PKC down-regulation decreased the extent of activation of PLD by Der p I by about 50%.
Discussion
The present study demonstrates that the house-dustmite allergen, Der p I, stimulates PLD activity in PBMC from allergic patients. PLD activity was measured through the formation of PEt from labeled phospholipids, predominantly PC, which is considered the definitive assay for PLD activity (Gomez-Munoz et al., 1994; Liscovitch and Chalifa, 1994) .
Although our results were obtained from PBMC instead of enriched specific cell types, according to previous results (Stanford et al., 1991; Bacon et al., 1998) , Der p I-induced PLD activation was probably involved in T cell activation. For several years, it appeared that the early events of T cell activation were involved with PLC that catalyze the hydrolysis of PIP 2 into the second messenger, inositol 1,4,5-triphosphate (IP 3 ) and DAG (Berridge and Irvine, 1984) . However, several subsequent studies have emphasized the role of tyrosine phosphorylation events in T cell activation, and two recent studies have cast doubt on the necessity of phosphoinositide hydrolysis for T cell activation (June et al., 1990; Mustelin et al., 1990) . Several investigators have suggested that activation of PLD resulting in PA production may be an important intracellular signaling pathway and that the PA 3 H]palmitate before treatment with Der p 1 (10 µg/ml) for 30 min, followed by the measurement of relative PLD activity. Results are the mean ± SD from the experiment performed in triplicate. Statistics were determined using one-way ANOVA. *, p < 0.05 (vs PMA none treatment).
has mitogenic properties for various cell types (Exton, 1994) . Furthermore, more recent reports demonstrate that the antigen receptors on mature and immature T cells were coupled to PLD activation and that this activation is dependent upon PKC (Reid et al., 1997) .
In the present experiments, Der p I-induced PLD activation partially occurred as a consequence of PKC activation. This conclusion is based on the following results. Der p I-induced PLD activation was significantly abrogated by prior long-term exposure to PMA, which has been demonstrated to lead to PKC down-regulation in various cell types (Kraft et al., 1994) . The expression of mRNA for PKC-α, -β, -ε, and -ζ, but not-γ or -δ isozymes, has been detected in T cells (Freire-Moar et al., 1991) . Among these isotypes, the most striking changes were observed in PKC-ε isozyme in T cells activation (Harris et al., 1995) . As PKC-ζ is phorbol independent and not responsive to PKC down-regulation (Wang et al., 1995) , we could hypothesize that PKC-α or PKC-β alone or in conjunction with PKC-ε mediates Der p I-induced PLD activity. The relationship between PKC isoforms and PLD activity is the subject of ongoing study in our laboratory.
In our present study, even if the PKC was downregulated, Der p I-induced PLD activation was not completely inhibited, implying that another activation mechanism was needed for Der p I-induced PLD activation. PLD activity can be regulated by multiple types of signals (Liscovitch and Chalifa, 1994) . Both heterotrimeric and low molecular weight G proteins have been implicated in PLD activation. Many investigators suggested a key role for the involvement of the small molecular weight G proteins ADP-ribosylation factor (ARF) and RhoA in agonist-induced PLD activation in certain cell types (Gomez-Cambronero and Keire, 1998) . A recent report demonstrated that the potent agonist of T cell activation, RANTES, induced potent PLD activation by the activation of ARF and RhoA (Bacon et al., 1998) . However, it is not yet clear whether these small molecular weight G proteins may be the regulator for Der p I-induced PLD activation.
In conclusion, the data presented in this report demonstrates that the HDM allergen, Der p I, induces activation of PLD in PBMC from allergic patients. The present study also suggests that Der p I-induced stimulation of PLD activity is partially dependent upon PKC. The exact mechanism regulating PLD in Der p Istimulated PBMC from allergic patients remains to be dissected.
